Industry: Medical Devices & Consumables
Published Date: 2026-01-08
Pages: 116 Pages
Report ld: 5595986
Request Sample
Customized Report
NGAL ELISA Kit Market Size(US$)

CAGR 2026-2032
10.2%
Market Size,2032
USD 156
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
The global NGAL ELISA Kit market was valued at US$ 79.7 million in 2025 and is anticipated to reach US$ 156 million by 2032, at a CAGR of 10.2% from 2026 to 2032.
The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on NGAL ELISA Kit competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
The NGAL(Neutrophil Gelatinase-Associated Lipocalin) Kit is mainly used to quantitatively determine the NGAL content in human blood (including whole blood, serum, plasma) or urine, which is helpful in assisting the diagnosis of renal function damage in clinical practice. According to different detection methods and uses, NGAL test kits can be divided into various types, such as ELISA, immunochromatography and others. This report mainly focuses on NGAL ELISA kit market.
The North American market for NGAL ELISA Kit is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The Asia-Pacific market for NGAL ELISA Kit is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
Major global manufacturers of NGAL ELISA Kit include Immunodiagnostics, DiaPharma, Thermo Fisher Scientific, Wondfo Biotech, BioPorto, Hycult Biotech, LAB MARK, EasyDiagnosis, Aoruida Biology, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.
This report delivers a comprehensive overview of the global NGAL ELISA Kit market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding NGAL ELISA Kit. The NGAL ELISA Kit market size, estimates, and forecasts are provided in terms of sales volume (K Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global NGAL ELISA Kit market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist NGAL ELISA Kit manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for NGAL ELISA Kit manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines NGAL ELISA Kit sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 NGAL ELISA Kit Market Overview
1.1 Product Definition
1.2 NGAL ELISA Kit by Type
1.2.1 Global NGAL ELISA Kit Market Value by Type: 2025 vs 2032
1.2.2 Human NGAL ELISA Kit
1.2.3 Rat NGAL ELISA Kit
1.2.4 Mouse NGAL ELISA Kit
1.2.5 Others
1.3 NGAL ELISA Kit by Application
1.3.1 Global NGAL ELISA Kit Market Value by Application: 2025 vs 2032
1.3.2 Clinical
1.3.3 Scientific Research
1.4 Global NGAL ELISA Kit Market Size Estimates and Forecasts
1.4.1 Global NGAL ELISA Kit Revenue 2021–2032
1.4.2 Global NGAL ELISA Kit Sales 2021–2032
1.4.3 Global NGAL ELISA Kit Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 NGAL ELISA Kit Market Competition by Manufacturers
2.1 Global NGAL ELISA Kit Sales Market Share by Manufacturers (2021–2026)
2.2 Global NGAL ELISA Kit Revenue Market Share by Manufacturers (2021–2026)
2.3 Global NGAL ELISA Kit Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of NGAL ELISA Kit, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of NGAL ELISA Kit, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of NGAL ELISA Kit, Product Types and Applications
2.7 Global Key Manufacturers of NGAL ELISA Kit, Date of Entry into the Industry
2.8 Global NGAL ELISA Kit Market Competitive Situation and Trends
2.8.1 Global NGAL ELISA Kit Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global NGAL ELISA Kit Players Market Share by Revenue
2.8.3 Global NGAL ELISA Kit Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global NGAL ELISA Kit Market Scenario by Region
3.1 Global NGAL ELISA Kit Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global NGAL ELISA Kit Sales by Region: 2021–2032
3.2.1 Global NGAL ELISA Kit Sales by Region: 2021–2026
3.2.2 Global NGAL ELISA Kit Sales by Region: 2027–2032
3.3 Global NGAL ELISA Kit Revenue by Region: 2021–2032
3.3.1 Global NGAL ELISA Kit Revenue by Region: 2021–2026
3.3.2 Global NGAL ELISA Kit Revenue by Region: 2027–2032
3.4 North America NGAL ELISA Kit Market Facts & Figures by Country
3.4.1 North America NGAL ELISA Kit Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America NGAL ELISA Kit Sales by Country (2021–2032)
3.4.3 North America NGAL ELISA Kit Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe NGAL ELISA Kit Market Facts & Figures by Country
3.5.1 Europe NGAL ELISA Kit Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe NGAL ELISA Kit Sales by Country (2021–2032)
3.5.3 Europe NGAL ELISA Kit Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific NGAL ELISA Kit Market Facts & Figures by Region
3.6.1 Asia Pacific NGAL ELISA Kit Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific NGAL ELISA Kit Sales by Region (2021–2032)
3.6.3 Asia Pacific NGAL ELISA Kit Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America NGAL ELISA Kit Market Facts & Figures by Country
3.7.1 Latin America NGAL ELISA Kit Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America NGAL ELISA Kit Sales by Country (2021–2032)
3.7.3 Latin America NGAL ELISA Kit Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa NGAL ELISA Kit Market Facts & Figures by Country
3.8.1 Middle East and Africa NGAL ELISA Kit Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa NGAL ELISA Kit Sales by Country (2021–2032)
3.8.3 Middle East and Africa NGAL ELISA Kit Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global NGAL ELISA Kit Sales by Type (2021–2032)
4.1.1 Global NGAL ELISA Kit Sales by Type (2021–2026)
4.1.2 Global NGAL ELISA Kit Sales by Type (2027–2032)
4.1.3 Global NGAL ELISA Kit Sales Market Share by Type (2021–2032)
4.2 Global NGAL ELISA Kit Revenue by Type (2021–2032)
4.2.1 Global NGAL ELISA Kit Revenue by Type (2021–2026)
4.2.2 Global NGAL ELISA Kit Revenue by Type (2027–2032)
4.2.3 Global NGAL ELISA Kit Revenue Market Share by Type (2021–2032)
4.3 Global NGAL ELISA Kit Price by Type (2021–2032)
5 Segment by Application
5.1 Global NGAL ELISA Kit Sales by Application (2021–2032)
5.1.1 Global NGAL ELISA Kit Sales by Application (2021–2026)
5.1.2 Global NGAL ELISA Kit Sales by Application (2027–2032)
5.1.3 Global NGAL ELISA Kit Sales Market Share by Application (2021–2032)
5.2 Global NGAL ELISA Kit Revenue by Application (2021–2032)
5.2.1 Global NGAL ELISA Kit Revenue by Application (2021–2026)
5.2.2 Global NGAL ELISA Kit Revenue by Application (2027–2032)
5.2.3 Global NGAL ELISA Kit Revenue Market Share by Application (2021–2032)
5.3 Global NGAL ELISA Kit Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Immunodiagnostics
6.1.1 Immunodiagnostics Company Information
6.1.2 Immunodiagnostics Description and Business Overview
6.1.3 Immunodiagnostics NGAL ELISA Kit Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Immunodiagnostics NGAL ELISA Kit Product Portfolio
6.1.5 Immunodiagnostics Recent Developments/Updates
6.2 DiaPharma
6.2.1 DiaPharma Company Information
6.2.2 DiaPharma Description and Business Overview
6.2.3 DiaPharma NGAL ELISA Kit Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 DiaPharma NGAL ELISA Kit Product Portfolio
6.2.5 DiaPharma Recent Developments/Updates
6.3 Thermo Fisher Scientific
6.3.1 Thermo Fisher Scientific Company Information
6.3.2 Thermo Fisher Scientific Description and Business Overview
6.3.3 Thermo Fisher Scientific NGAL ELISA Kit Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Thermo Fisher Scientific NGAL ELISA Kit Product Portfolio
6.3.5 Thermo Fisher Scientific Recent Developments/Updates
6.4 Wondfo Biotech
6.4.1 Wondfo Biotech Company Information
6.4.2 Wondfo Biotech Description and Business Overview
6.4.3 Wondfo Biotech NGAL ELISA Kit Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Wondfo Biotech NGAL ELISA Kit Product Portfolio
6.4.5 Wondfo Biotech Recent Developments/Updates
6.5 BioPorto
6.5.1 BioPorto Company Information
6.5.2 BioPorto Description and Business Overview
6.5.3 BioPorto NGAL ELISA Kit Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 BioPorto NGAL ELISA Kit Product Portfolio
6.5.5 BioPorto Recent Developments/Updates
6.6 Hycult Biotech
6.6.1 Hycult Biotech Company Information
6.6.2 Hycult Biotech Description and Business Overview
6.6.3 Hycult Biotech NGAL ELISA Kit Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Hycult Biotech NGAL ELISA Kit Product Portfolio
6.6.5 Hycult Biotech Recent Developments/Updates
6.7 LAB MARK
6.7.1 LAB MARK Company Information
6.7.2 LAB MARK Description and Business Overview
6.7.3 LAB MARK NGAL ELISA Kit Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 LAB MARK NGAL ELISA Kit Product Portfolio
6.7.5 LAB MARK Recent Developments/Updates
6.8 EasyDiagnosis
6.8.1 EasyDiagnosis Company Information
6.8.2 EasyDiagnosis Description and Business Overview
6.8.3 EasyDiagnosis NGAL ELISA Kit Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 EasyDiagnosis NGAL ELISA Kit Product Portfolio
6.8.5 EasyDiagnosis Recent Developments/Updates
6.9 Aoruida Biology
6.9.1 Aoruida Biology Company Information
6.9.2 Aoruida Biology Description and Business Overview
6.9.3 Aoruida Biology NGAL ELISA Kit Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 Aoruida Biology NGAL ELISA Kit Product Portfolio
6.9.5 Aoruida Biology Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 NGAL ELISA Kit Industry Chain Analysis
7.2 NGAL ELISA Kit Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 NGAL ELISA Kit Production Mode & Process Analysis
7.4 NGAL ELISA Kit Sales and Marketing
7.4.1 NGAL ELISA Kit Sales Channels
7.4.2 NGAL ELISA Kit Distributors
7.5 NGAL ELISA Kit Customer Analysis
8 NGAL ELISA Kit Market Dynamics
8.1 NGAL ELISA Kit Industry Trends
8.2 NGAL ELISA Kit Market Drivers
8.3 NGAL ELISA Kit Market Challenges
8.4 NGAL ELISA Kit Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global NGAL ELISA Kit market is projected to grow from US$ 79.7 million in 2025 to US$ 156 million by 2032, at a CAGR of 10.2% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2026-03-25
Pages: 145
USD 4900.00
(Single User License)
The global NGAL ELISA Kit market size was US$ 79.7 million in 2025 and is forecast to reach a readjusted size of US$ 156 million by 2032 with a CAGR of 10.2% during the forecast period 2026-2032.
Published Date: 2026-03-25
Pages: 79
USD 4250.00
(Single User License)
The global market for NGAL ELISA Kit was estimated to be worth US$ 79.7 million in 2025 and is projected to reach US$ 156 million, growing at a CAGR of 10.2% from 2026 to 2032.
Published Date: 2026-01-08
Pages: 104
USD 3950.00
(Single User License)
The global NGAL ELISA Kit market size was US$ 73 million in 2024 and is forecast to a readjusted size of US$ 143 million by 2031 with a CAGR of 10.2% during the forecast period 2025-2031.
Published Date: 2025-08-01
Pages: 77
USD 4250.00
(Single User License)
The global NGAL ELISA Kit market is projected to grow from US$ 73 million in 2024 to US$ 143 million by 2031, at a CAGR of 10.2% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-08-01
Pages: 134
USD 4900.00
(Single User License)
The global market for NGAL ELISA Kit was estimated to be worth US$ 73 million in 2024 and is forecast to a readjusted size of US$ 143 million by 2031 with a CAGR of 10.2% during the forecast period 2025-2031.
Published Date: 2025-03-10
Pages: 109
USD 3950.00
(Single User License)
The global market for NGAL ELISA Kit was valued at US$ 73 million in the year 2024 and is projected to reach a revised size of US$ 143 million by 2031, growing at a CAGR of 10.2% during the forecast period.
Published Date: 2025-03-10
Pages: 81
USD 2900.00
(Single User License)
The global NGAL ELISA Kit market is projected to grow from US$ 73 million in 2024 to US$ 131 million by 2030, at a Compound Annual Growth Rate (CAGR) of 10.2% during the forecast period.
Published Date: 2024-11-15
Pages: 129
USD 4900.00
(Single User License)
The global NGAL ELISA Kit revenue was US$ 67 million in 2023 and is forecast to a readjusted size of US$ 131 million by 2030 with a CAGR of 10.2% during the review period (2024-2030).
Published Date: 2024-11-15
Pages: 106
USD 4350.00
(Single User License)
The global market for NGAL ELISA Kit was estimated to be worth US$ 67 million in 2023 and is forecast to a readjusted size of US$ 131 million by 2030 with a CAGR of 10.2% during the forecast period 2024-2030.
Published Date: 2024-11-15
Pages: 109
USD 3950.00
(Single User License)
The global NGAL ELISA Kit market is projected to grow from US$ 79.7 million in 2025 to US$ 156 million by 2032, at a CAGR of 10.2% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2026-03-25
Pages: 145
The global NGAL ELISA Kit market size was US$ 79.7 million in 2025 and is forecast to reach a readjusted size of US$ 156 million by 2032 with a CAGR of 10.2% during the forecast period 2026-2032.
Published: 2026-03-25
Pages: 79
The global market for NGAL ELISA Kit was estimated to be worth US$ 79.7 million in 2025 and is projected to reach US$ 156 million, growing at a CAGR of 10.2% from 2026 to 2032.
Published: 2026-01-08
Pages: 104
The global NGAL ELISA Kit market size was US$ 73 million in 2024 and is forecast to a readjusted size of US$ 143 million by 2031 with a CAGR of 10.2% during the forecast period 2025-2031.
Published: 2025-08-01
Pages: 77
The global NGAL ELISA Kit market is projected to grow from US$ 73 million in 2024 to US$ 143 million by 2031, at a CAGR of 10.2% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-08-01
Pages: 134
The global market for NGAL ELISA Kit was estimated to be worth US$ 73 million in 2024 and is forecast to a readjusted size of US$ 143 million by 2031 with a CAGR of 10.2% during the forecast period 2025-2031.
Published: 2025-03-10
Pages: 109
The global market for NGAL ELISA Kit was valued at US$ 73 million in the year 2024 and is projected to reach a revised size of US$ 143 million by 2031, growing at a CAGR of 10.2% during the forecast period.
Published: 2025-03-10
Pages: 81
The global NGAL ELISA Kit market is projected to grow from US$ 73 million in 2024 to US$ 131 million by 2030, at a Compound Annual Growth Rate (CAGR) of 10.2% during the forecast period.
Published: 2024-11-15
Pages: 129
The global NGAL ELISA Kit revenue was US$ 67 million in 2023 and is forecast to a readjusted size of US$ 131 million by 2030 with a CAGR of 10.2% during the review period (2024-2030).
Published: 2024-11-15
Pages: 106
The global market for NGAL ELISA Kit was estimated to be worth US$ 67 million in 2023 and is forecast to a readjusted size of US$ 131 million by 2030 with a CAGR of 10.2% during the forecast period 2024-2030.
Published: 2024-11-15
Pages: 109
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now